Lifecore Biomedical Net Tangible Assets

The latest net tangible assets for LFCR is $21M as of March 2026. Investors often review this figure alongside Lifecore Biomedical's historical trend and sector peers before judging valuation or financial health.

A net tangible assets figure of $21M for LFCR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LFCR's net tangible assets ($21M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Lifecore Biomedical's net tangible assets against similar Materials names. You can also browse sector and industry screens on Stockcircle for a broader set of Materials companies and their key multiples and fundamentals.